On December 18, 2025, Novo Nordisk applied for FDA approval of a two-drug combination called CagriSema
Sample preparation An aliquot of 50 L of biological samples, i.e., rat plasma or brain tissue homogenates, was mixed with 50 L of IS working solution (50 ng/mL) and 200 L of methanol
The interaction concern is specific to people taking exogenous thyroid hormone, where absorption changes translate directly to dose changes
The bottom line If youre carrying extra weight, the cancer news is good and its getting better, and the beautiful part is that the protection is mostly your own body getting healthier, not a drug doing something you cant see
Common side effects of this medicine may include diarrhea, nausea, and headaches